Pricing Log in Create free account

Cadrenal Therapeutics, Inc. (CVKD) vs Lipella Pharmaceuticals Inc. (LIPO)

Cadrenal Therapeutics, Inc. and Lipella Pharmaceuticals Inc. are both Biotechnology companies. Cadrenal Therapeutics, Inc. and Lipella Pharmaceuticals Inc. are of similar size ($3.5M and $3.4M). Across the 9 metrics below, Cadrenal Therapeutics, Inc. leads on 5 and Lipella Pharmaceuticals Inc. on 4.

Valuation

Metric CVKD LIPO Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.78 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.29 0.64
EV/Sales n/m (3.31) 9.21
Earnings yield (449.54%) 0.00% (33.15%)
Free cash flow yield (320.05%) 0.00% (25.50%)

Profitability

Metric CVKD LIPO Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (275.16%) (361.77%) (56.36%)
Return on assets (199.59%) (236.36%) (48.04%)
Return on invested capital (427.54%) 0.00% 0.00%

Growth

Metric CVKD LIPO Biotechnology median
Revenue growth (TTM) — (7.29%) 6.02%
EPS growth (last fiscal year) 23.94% 22.24% 30.26%
Revenue growth, 5-year CAGR — (5.04%) 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CVKD LIPO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.73 3.24 4.72
Net debt to EBITDA 0.30 0.43 0.96

Dividend

Metric CVKD LIPO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CVKD LIPO Biotechnology median
Market cap 3.46m 3.39m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack